Florian Lipsmeier

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

Gennaro Pagano, Kirsten I. Taylor, Judith Anzures‐Cabrera et al. · New England Journal of Medicine · 2022 · 395 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Florian Lipsmeier, Kirsten I. Taylor, Timothy Kilchenmann et al. · Movement Disorders · 2018 · 268 citations · Full text

Health Professions, Health Informatics, Neurology +17

Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions

J.F. Sydow, Florian Lipsmeier, Vincent Larraillet et al. · PLoS ONE · 2014 · 160 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +16

Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study

Luciana Midaglia, Patricia Mulero, Xavier Montalbán et al. · Journal of Medical Internet Research · 2019 · 140 citations · Full text

Nursing, Health Informatics, Functional Assessment +16

A smartphone sensor-based digital outcome assessment of multiple sclerosis

Xavier Montalbán, Jennifer Graves, Luciana Midaglia et al. · Multiple Sclerosis Journal · 2021 · 112 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +17